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Abstract
Background: Concerns have been raised about the public health implications of the presence of antibiotic residues in 
the aquatic environment and their effect on the development of bacterial resistance. While there is information on 
antibiotic residue levels in hospital effluent from some other countries, information on antibiotic residue levels in 
effluent from Indian hospitals is not available. Also, concurrent studies on antibiotic prescription quantity in a hospital 
and antibiotic residue levels and resistant bacteria in the effluent of the same hospital are few. Therefore, we quantified 
antibiotic residues in waters associated with a hospital in India and assessed their association, if any, with quantities of 
antibiotic prescribed in the hospital and the susceptibility of Escherichia coli found in the hospital effluent.
Methods: This cross-sectional study was conducted in a teaching hospital outside the city of Ujjain in India. Seven 
antibiotics - amoxicillin, ceftriaxone, amikacin, ofloxacin, ciprofloxacin, norfloxacin and levofloxacin - were selected. 
Prescribed quantities were obtained from hospital records. The samples of the hospital associated water were analysed 
for the above mentioned antibiotics using well developed and validated liquid chromatography/tandem mass 
spectrometry technique after selectively isolating the analytes from the matrix using solid phase extraction. Escherichia 
coli isolates from these waters were tested for antibiotic susceptibility, by standard Kirby Bauer disc diffusion method 
using Clinical and Laboratory Standard Institute breakpoints.
Results: Ciprofloxacin was the highest prescribed antibiotic in the hospital and its residue levels in the hospital 
wastewater were also the highest. In samples of the municipal water supply and the groundwater, no antibiotics were 
detected. There was a positive correlation between the quantity of antibiotics prescribed in the hospital and antibiotic 
residue levels in the hospital wastewater. Wastewater samples collected in the afternoon contained both a higher 
number and higher levels of antibiotics compared to samples collected in the morning hours. No amikacin was found 
in the wastewater, but E.coli isolates from all wastewater samples were resistant to amikacin. Although ciprofloxacin 
was the most prevalent antibiotic detected in the wastewater, E.coli was not resistant to it.
Conclusions: Antibiotics are entering the aquatic environment of countries like India through hospital effluent. In-
depth studies are needed to establish the correlation, if any, between the quantities of antibiotics prescribed in 
hospitals and the levels of antibiotic residues found in hospital effluent. Further, the effect of this on the development 
of bacterial resistance in the environment and its subsequent public health impact need thorough assessment.
Background
Antibiotics are an important group of pharmaceuticals
used in health care for the treatment and prevention of
bacterial infections. Much of the antibiotic used in
humans and animals remains unmetabolized and thus a
significant amount is added to the environment via excre-
tion. This ultimately contributes to the residues of antibi-
otics in recipient waters. Antibiotics might also be added
to the environment from pharmaceutical plants and as a
result of the dumping of unused antibiotics [1,2].
Besides antibiotics, resistant bacteria also enter into the
aquatic environment from various sources [3]. It is not
yet very clear whether the presence of antibiotics in the
aquatic environment results in developing resistance in
the bacteria found there. However, there is growing con-
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cern about the presence of antibiotic residues in the
aquatic environment and their impact on resistance
development, toxicity to aquatic communities and ulti-
mately to public health [3-5].
Studies on antibiotic residues in hospital effluent and in
other environmental niches have been conducted mostly
in high-income countries, while studies in low- and mid-
dle-income settings are few and sparsely distributed [1,6-
9] and only one study has estimated antibiotic residues in
Indian hospital effluents [10]. Furthermore, concurrent
studies on antibiotic prescription quantity in a hospital,
antibiotic residue levels in its wastewater and resistant
bacteria in the effluent of the same hospital are few
[9,11,12].
The present study has quantified antibiotic residue lev-
els in the incoming water and waste water (referred to as
"hospital associated waters" or "water associated with the
hospital" in the text) of a hospital in India and their asso-
ciation, if any, with quantities of antibiotics prescribed in
the hospital and the antibiotic susceptibility of Escheri-
chia coli (E.coli) found in the hospital effluent.
Methods
Settings and sub-studies
This cross-sectional study was conducted in the state of
Madhya Pradesh in India. Specifically, the setting was the
500-bed teaching hospital attached to the R.D. Gardi
Medical College, situated in a rural area near Ujjain city.
Three sub-studies were conducted (i) quantification of
antibiotics prescribed in the inpatient wards of the hospi-
tal (ii) estimation of antibiotic residues in hospital-associ-
ated waters and (iii) determination of susceptibility
patterns in E.coli isolates obtained from the same waters.
Further, the inter-relationship, if any, between the results
obtained from these sub-studies was assessed.
Selection of antibiotics
Seven antibiotics from four major antibiotic groups -
amoxicillin (penicillins), ceftriaxone (cephalosporins),
amikacin (aminoglycosides) and ofloxacin, ciprofloxacin,
norfloxacin and levofloxacin (fluoroquinolones) - were
selected for the study. The selection was based on the
antibiotic prescription pattern in the inpatient wards of
the hospital, the degree of metabolism of antibiotics in
the human body, environmental stability and the known
and suspected environmental impact of an antibiotic
[1,13].
Antibiotic prescription study
To estimate antibiotic consumption, information regard-
ing antibiotics prescribed to patients around the same
time as water sampling (6 days), was obtained from the
hospital records. All the patients who were admitted dur-
ing this period were included. The World Health Organi-
zation's (WHOs) Anatomical Therapeutic Chemical
(ATC) classification index with defined daily doses
(DDDs) was used to classify the antibiotics prescribed
[14].
Selection of sampling sites
Three sampling sites were selected, taking into account
entry of safe water into the hospital system, its likelihood
of becoming contaminated by antibiotics and exit of anti-
biotic-contaminated water into the environment. Sam-
ples were collected from (i) incoming safe water sources
(Site 1) (ii) the point of exit of wastewater from inpatient
wards of the hospital (Site 2) and (iii) 100 metres down-
stream from the hospital in subsequent drains (Site 3).
Sampling protocol
Samples were collected twice- at 10:00 hrs and at 16:00
hrs. This was done as a safety measure as the dynamics of
movement of antibiotics in the drains were unknown.
Grab samples (2250 ml) from each site were collected -
two litres for analysis of antibiotic residues and 250 ml for
analysis of antibacterial susceptibility - and were stored in
an icebox at 4°C until they reached the analytical labora-
tories. Samples for antibiotic residue analysis were col-
lected in screw-capped amber bottles wrapped in silver
foil to prevent photo-degradation and were transported
to the Shriram Institute for Industrial Research (SIIR) in
New Delhi within 12 hrs. Samples for studying antibiotic
susceptibility were collected in sterilized and paper-
wrapped, 300-ml BOD bottles and were transferred
immediately to the microbiology laboratory of the R.D.
Gardi Medical College. In the chemical laboratory the
samples were kept at - 20°C until analysis, while in the
microbiology laboratory the analysis started immediately.
Analysis of samples for the presence of antibiotic residues
The determination of the seven antibiotics in the hospital
associated waters involved development and validation of
a method [15], using liquid chromatography/tandem
mass spectrometry (LC-MS/MS), (Waters 2695 series
Alliance quaternary liquid chromatography system,
Waters, USA, with a triple quadruple mass spectrometer,
Quatro-micro API, Micromass, UK, equipped with elec-
trospray interface and Masslynx 4.1 software (Micro-
mass, UK) for data acquisition and processing). The
instrument was operated in the multiple reaction moni-
toring positive ion mode. Nitrogen was used as a nebuli-
zation gas as well as dissolvation gas and was delivered at
a flow rate of 50 l/hr and 750 l/hr respectively. Other typ-
ical MS settings are given in Table 1. Mass spectra were
acquired over the scan range of m/z from 100 to 650 Dal-
ton. For MS/MS mode, product-ion scan mass spectra of
protonated molecules of the various antibiotics were
acquired in the mass range of 50 to 600 Dalton. Two dif-Diwan et al. BMC Public Health 2010, 10:414
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ferent characteristic fragments were monitored for each
analyte to confirm the presence of the residues of various
antibiotics. Table 2 shows the precursor ion and the
daughter ions for the individual antibiotic. Quantification
was done on the most intense ion transition.
The analysis was carried out on Waters X Terra MS C-
18 column (2.1 mm × 100 mm, 5 μ particle size) using
three different injections of each sample solution in three
different solvent systems under isocratic conditions: (a)
For norfloxacin, ofloxacin, ciprofloxacin and levofloxa-
cin: A mixture (50:50 by volume) of solution of 0.1% for-
mic acid in water and 0.1% formic acid in acetonitrile
delivered at a flow rate of 0.2 ml/min; (b) For amikacin: A
mixture (50:50 by volume) of solution of 0.1% formic acid
in water and 0.1% formic acid in methanol delivered at a
flow rate 0.2 ml/min and (c) For amoxicillin and ceftriax-
one : A mixture (50:50 by volume) of solution of 0.1% for-
mic acid in water and 0.1% formic acid in acetonitrile
delivered at a flow rate 0.2 ml/min. The chromatographic
run for each of the injections for all the antibiotics was
completed within five minutes and the retention time for
each analyte is mentioned in Table 2.
All solvents/chemicals used for the purpose were
HPLC grade/analytical reagent grade. HPLC grade water,
methanol and acetonitrile were purchased from Merck
Specialities Private Limited, Mumbai, India, while acetic
acid, formic acid, sulphuric acid, and triethylamine were
purchased from S.D. Fine-Chem Limited, Mumbai, India.
Preparation of sample solution for hospital associated 
water
Approximately 100 ml of accurately measured sample of
the hospital associated water, filtered through 0.45-μ-fil-
ter membrane and acidified with sulphuric acid (pH 3.0)
was loaded on an activated Waters Sep-Pak C18 cartridge
(activated with 5 ml methanol, 5 ml methanol/water
(50:50) followed by 5 ml acidified water at pH 3).
The cartridge was then washed with 5 ml acidified
water and the adsorbed compounds were eluted with 5
ml eluant (5% solution of triethylamine in methanol). The
eluant was evaporated off to almost dryness at 50°C using
Nitrogen evaporator (Labconco Corporation, Kansas
City, Missouri, USA). The dried extract was then dis-
solved in acetonitrile and the final volume made to 1 ml.
This sample solution was injected thrice under three dif-
ferent mobile phase conditions (as given earlier) above for
the different antibiotics.
Preparation of standard solutions for calibration
Standard solutions for calibration were prepared with the
following concentrations:
Table 2: Data for retention time for different antibiotics, mass of the precursor ion monitored and mass of the daughter 
ions monitored
Antibiotic Retention time (minutes) Precursor ion [M + H] m/z Daughter ion I m/z Daughter ion II m/z
Amoxicillin 1.60 366.24 114 208
Ceftriaxone 1.78 555.25 324.14 396.2
Amikacin 1.16 586.48 425.43 264.19
Ofloxacin 1.05 362.29 318.22 261.13
Ciprofloxacin 1.08 333.2 231.05 245.03
Norfloxacin 1.02 320.2 231.02 204.6
Levofloxacin 1.1 362.22 261.13 318.24
Table 1: Mass spectrometric conditions used for determination of different antibiotics using LC-MS/MS
Antibiotic Source 
temp (°C)
Dissolvation 
temp (°C)
Capillary 
voltage (Kv)
Cone 
voltage (V)
Collision 
energy
Dwell time (milli sec)
Amoxicillin 120 450 3 7 20 20
Ceftriaxone 120 450 3 20 15 20
Amikacin 120 450 3 20 15 20
Ofloxacin 120 450 3 22 22 20
Ciprofloxacin 120 450 3 20 30 20
Norfloxacin 120 450 3 20 35 20
Levofloxacin 120 450 3 20 25 20Diwan et al. BMC Public Health 2010, 10:414
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1.Combined calibration standard solutions for ofloxa-
cin, ciprofloxacin, norfloxacin and levofloxacin at 
concentration levels of 2.5, 5.0, 10.0, 25.0, 50.0, 100.0, 
250.0, 500.0 ng/ml respectively in the range 2.5 to 500 
ng/ml.
2.Calibration standard solutions for amikacin at con-
centration levels of 50.0, 100.0, 250.0, 500.0 ng/ml 
respectively in the range 50 to 500 ng/ml.
3.Calibration standard solutions for ceftriaxone at 
concentration levels of 500.0, 1000.0, 1250.0, 2500.0 
and 5000 ng/ml respectively in the range 500 to 5000 
ng/ml.
4.Calibration standard solutions for amoxicillin at 
concentration levels of 100.0, 200.0, 500.0, 1000.0 and 
1500.0 ng/ml respectively in the range 100 to 1500 ng/
ml.
Method Performance Characteristics
The method was validated as per the International Con-
ference on Harmonisation (ICH) and the Eurachem
guidelines [16,17]. Validation studies were performed for
the various parameters i.e. linearity, precision (both inter-
day and intraday), accuracy (percent recoveries), limit of
detection, limit of quantification, specificity and selectiv-
ity. The results for the various validation parameters are
tabulated in Table 3. All validation parameters were
found well within the acceptable criteria of the guidelines.
E.coli antibiotic susceptibility study
The estimation of total coliform group and fecal coliform
group was done by determining the Most Probable Num-
ber (MPN) of bacteria in test samples, using standard
multiple tube technique [18]. The test procedure
included three phases, namely presumptive, confirmative
& completed phase. For drinking water samples the pre-
sumptive phase consisted of, 5 tubes of 20 ml and 10
tubes containing 10 ml of lauryl tryptose broth medium.
No dilutions were made for these samples. For wastewa-
ter samples, dilution were made with lauryl tryptose
broth medium and 5 tubes for each dilution of 10 ml, 1 ml
and 0.1 ml were used. All inoculated tubes were incu-
bated at 35°C ± 0.5°C for 24-48 hrs. Tubes showing pres-
ence of growth (turbidity) with or without gas were
submitted to confirmatory phase. All presumptive tubes
showing positive results were gently shaken. Using sterile
loop of 3 mm diameter, two loopful of culture was added
to brilliant green lactose bile broth tubes and incubated at
35°C ± 0.5°C. Formation of gas within 48 hrs was taken as
positive confirmation. Simultaneously EC broth tubes
were also inoculated for completed phase and incubated
at 44.5°C in water bath. Tubes showing acid and gas pro-
duction within 24 hrs was taken as positive result indicat-
ing presence of fecal coliforms in the samples. Further,
E.coli were confirmed by sub culturing on MacConkey
agar to obtain pure culture. Following biochemical con-
firmation by standard biochemical tests, confirmed E.
coli isolates were tested for susceptibilities using the stan-
dard Kirby Bauer disc diffusion method for seven antibi-
otics according to the Clinical and Laboratory Standard
Institute (CLSI) breakpoints [19]. After matching turbid-
ity of the inoculum with McFarland 0.5 standard, the cot-
ton swab dipped into inoculum was inoculated on the
Muller-Hinton agar. The antibiotic discs were placed on
the inoculated plates and then incubated at 35°C ± 0.5°C
for about 18-20 hours. The diameter (in millimeters) of
the zone of inhibition was measured and interpreted as
resistant, intermediate or sensitive using CLSI guidelines
for the respective antibiotic [19]. Reference strain ATCC
25922 of E. coli was used for quality control.
All the chemicals and media used were of standard
grade and procured from HiMedia Laboratories Private
Limited, Mumbai, India.
Table 3: Summary of the validation parameters for the LC-MS/MS methods for the determination of residual antibiotics in 
water samples from a hospital in Ujjain, India
Antibiotics Correlation 
coefficient r2
Coefficient of Variation (%RSD) LOD μg/l LOQ μg/l % Recovery n = 5
Interday n = 6 Intraday n = 6
Amoxicillin 0.994 5.2 5.6 0.5 1.0 85 (%RSD 5.6)
Ceftrixone 0.997 2.1 1.8 2.5 5.0 84 (%RSD 4.1)
Amikacin 0.990 4.8 4.3 0.25 0.5 92 (%RSD 3.8)
Ofloxacin 0.999 3.1 2.57 0.01 0.025 95 (%RSD 3.7)
Ciprofloxacin 0.999 3.2 3.03 0.01 0.025 98 (%RSD 4.5)
Norfloxacin 0.999 3.4 3.02 0.01 0.025 90 (%RSD 3.2)
Levofloxacin 0.999 3.12 2.96 0.01 0.025 93 (%RSD 2.8)
LOD: Limit of detection; LOQ: Limit of quantificationDiwan et al. BMC Public Health 2010, 10:414
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Data management and statistical analysis
Data on antibiotic prescription, antibiotic residue levels
and antibiotic susceptibility analysis was entered and
analysed in SPSS 17 [20]. The results of prescription data
are presented as the total amount of antibiotics pre-
scribed in milligrams (mg) during the six days and num-
ber of defined daily doses (DDDs) [14]. The amount of
antibiotic residue levels is presented in μg/l. To determine
the relationship between quantities of antibiotic pre-
scribed and antibiotic residue levels obtained in hospital
wastewater, Spearman rank correlation was performed.
Ethical approval
Approval for the study was obtained from the ethical
committee of the R.D. Gardi Medical College, Ujjain.
Results
Prescription studies showed that ciprofloxacin was the
most commonly prescribed antibiotic (Table 4).
The results of the antibiotic residue studies are summa-
rized in Table 5. These studies showed that in samples
from the municipal water supply and the groundwater, no
antibiotics were present. Four of the 7 antibiotics studied
were detected in the analysed wastewater samples. All the
detected antibiotics were from the fluoroquinolone
group, the highest concentration being that of ciprofloxa-
cin (236.6 μg/l). Samples collected from site 3 located 100
metres from the hospital showed a higher number of
antibiotics and also higher residue levels than the site
closer to the hospital (Site 2). Samples collected in the
afternoon (16:00) showed a relatively higher number of
antibiotics and also higher residue levels of antibiotics
compared to samples collected in the morning hours
(10:00). Spearman's rank correlation was positive (r =
0.29; p = 0.51) between antibiotic prescription data and
a n t i b i o t i c  r es i d u e  l ev e l s  i n  h os p i t a l  was t ewa t e r  ( a l l  t h e
antibiotics). When only antibiotics from the fluoroqui-
nolone group were examined, correlation was positive
and higher (r = 0.80; p = 0.2).
No E.coli were detected in the municipal water supply,
however,  E.coli  were found in the groundwater and
s h o w e d  r e s i s t a n c e  t o  c i p r o f l o x a c i n ,  i n t e r m e d i a t e  r e s i s -
tance to amikacin and sensitivity to the other antibiotics
tested (Table 6). E.coli from all wastewater samples were
resistant to amikacin and sensitive to amoxicillin, with
only E.coli from site 2 showing intermediate resistance to
ciprofloxacin. Thus, no specific relationship between
E.coli susceptibility/resistance and antibiotic prescription
and/or residue level in wastewater was discernible.
Discussion
To our knowledge, this is the first study in India, which
has attempted to quantify concurrently, in the same hos-
pital, consumption of antibiotics, estimation of antibiotic
residues in hospital-associated waters and antibiotic sen-
sitivity amongst E.coli found in these waters.
Table 4: Prescribed quantities of targeted antibiotics, and their respective DDDs in inpatient wards of a hospital in Ujjain, 
India
Antibiotics ATC code Quantity of prescribed 
antibiotics/6 days (in mg)
No. of patients to whom 
antibiotic was prescribed
DDD (mg) No of DDDs
Penicillins
Amoxicillin J01CA04 19150 4 1000 19.15
Cephalosporins
Ceftriaxone J01DD04 126700 24 2000 63.4
Amino glycosides
Amikacin J01GB06 63825 26 1000 63.8
Fluoroquinolones
Ofloxacin J01MA01 2700 (O) 4 400 6.8
4200 (P) 400 10.5
Ciprofloxacin J01MA02 134700 (O) 66 1000 134.7
29000 (P) 500 58.0
Norfloxacin J01MA06 47600 (O) 23 800 59.5
Levofloxacin J01MA12 3000 (O) 2 500 6
O = orally administered, P = parenterally administeredDiwan et al. BMC Public Health 2010, 10:414
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From this study, it appeared that some of the antibiotics
prescribed to the patients in hospitals are reaching the
nearby aquatic environment. There was a positive,
(though not statistically significant) correlation between
antibiotic prescription quantity and residue levels in hos-
pital effluent. Specifically for fluoroquinolones, the corre-
lation was high. The reason for it not being statistically
significant could be the small sample size in this study.
Watkinson et al [21] also showed that the presence of
antibiotics in hospital effluent depended on the volume
of antibiotic prescription. They also found a positive cor-
relation, which was not statistically significant. There are
factors other than prescription volume that can play an
important role in the quantities of antibiotics detected in
the hospital effluent like the metabolism of antibiotics,
their stability in the environment, temperature, water
flow rate, time of sample collection, matrix effect, etc
[1,5].
Antibiotics from the fluoroquinolone group have also
been found in hospital wastewater in other parts of the
world. Amongst fluoroquinolones, ciprofloxacin was the
most commonly found antibiotic in hospital effluent [1,8-
11,22-24]. High residue levels of fluoroquinolones in the
aquatic environment can cause genotoxic effects and can
modify bacterial strains like Salmonella typhimurium at a
residue level as low as 5 μg/l for norfloxacin and 25 μg/l
for ciprofloxacin [25]. In our study, the concentration of
norfloxacin (6.4-29.6 μg/l) and ciprofloxacin (2.20-236.6
μg/l) in the drains was high, and this is a matter of con-
cern in terms of its wider public health impact.
Table 5: Levels of monitored antibiotics (μg/l) in waters associated with a hospital in Ujjain, India using LC-MS/MS
Antibiotics Site 1 Site 2 Site 3
Ground 
Water
Municipal 
Water
At 10:00 At 16:00 At 10:00 At 16:00
A m o x i c i l l i n - -- -- -- -- -- -
C e f t r i a x o n e - -- -- -- -- -- -
Amikacin -- -- -- -- -- --
Ofloxacin -- -- -- 4.5 5.6 7.5
Ciprofloxacin -- -- 2.2 218.3 67.3 236.6
Norfloxacin -- -- -- 6.4 29.6 22.8
Levofloxacin -- -- -- 5.0 6.8 8.8
-- = Below Detection Limit
Site 1 = Incoming safe water (received in hospital only once a day)
Site 2 = At the point of exit of inpatient wards of the hospital
Site 3 = 100 metres from the hospital in subsequent drains
Table 6: Antibiotic susceptibility of E.coli found in samples taken from waters associated with a hospital in Ujjain, India
Disc Concentration (μg) Site 1* Site 2 Site 3
Ground Water At 10:00 At 16:00 At 10:00 At 16:00
Amoxicillin 30 S S S S S
Ceftriaxone 30 S S S I I
Amikacin 30 I R R R R
Ofloxacin 5 S I S S S
Ciprofloxacin 5 R I I S S
N o r f l o x a c i n 1 0 S SSSI
Levofloxacin 5 S S S I I
R= Resistant; I= Intermediate; S= Sensitive
Site 1 = Incoming safe water (received in hospital only once a day) *No E. coli was detected in the municipal water supply.
Site 2 = At the point of exit of inpatient wards of the hospital.
Site 3 = 100 metres from the hospital in subsequent drains.Diwan et al. BMC Public Health 2010, 10:414
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Ceftriaxone residue was not detected in any of the sam-
ples analyzed, despite the fact that it was one of the major
antibiotics prescribed in the hospital. Neither have ceftri-
axone and other antibiotics with the β -lactam ring gener-
ally been detected in hospital effluent elsewhere. Reasons
for their non-detection have been cited as the easy degra-
dation of the β -lactam ring, its high metabolic rate and
the process of decarboxylation [1].
Results from the sampling repeated at the same point
indicated that there were considerable variations in anti-
biotic concentrations detected at the same place over
time. The residue levels of all the antibiotics from the flu-
oroquinolone group were higher at 16:00 hrs than at
10:00 hrs. Lindberg et al. [22] also reported considerable
variation in residue levels when sampling was done at
various times of the day at the same place. Such temporal
variations might arise due to variations in the administra-
tion of antibiotics during the course of the day, water
usage (and hence wastewater flow), as well as various
pharmacokinetic factors such as metabolism, half-life and
excretion rate [1,5]. In addition, other processes such as
sorption, hydrolysis and photolysis may influence the
concentrations detected in wastewater at any particular
time. In general, however, very little information is avail-
able on the temporal, spatial and diurnal behaviour of
antibiotics in the aquatic environment. Longitudinal sam-
pling strategies like monitoring of hospital effluents for
antibiotic residues over several days with recording also
of flow characteristics is needed to assess the potential
risks associated with the release of these residues on envi-
ronment in general and resistance in particular.
Several studies have documented the presence of anti-
biotic-resistant bacteria in the aquatic environment in
general and hospital effluent in particular [3]. It is not yet
clearly established that the mere presence of antibiotic
residues in the aquatic environment by itself influences
the development of resistance in natural bacterial com-
munities. It has been suggested that other factors like the
density of resistant bacteria, duration of exposure to the
antibiotic and presence of a favourable environment need
to be considered as well [3]. In our study, amikacin resi-
due was not detected in any of the analyzed samples but
nevertheless,  E. coli from all the wastewater samples
showed resistance to this antibiotic and even E.coli iso-
lated from ground water displayed an intermediate
behaviour. In contrast, none of the E.coli isolated from
the wastewater samples was resistant to ciprofloxacin but
showed intermediate behaviour in three samples, though
high levels of ciprofloxacin residue were detected in the
wastewater.
Antibiotics have been detected earlier in hospital efflu-
ent in high-income countries [3]. The present study has
highlighted the fact that antibiotics also enter the aquatic
environment through hospital effluent in low- and mid-
dle-income countries. Unlike high-income countries, the
situation can become more problematic in low- and mid-
dle-income countries, where resource constraints might
result in untreated wastewater. In India, for example, not
much wastewater undergoes any type of treatment and
along with other pollutants; antibiotics must also be find-
ing their way into recipient waters like rivers, lakes, reser-
voirs, etc. In situations where the wastewater is not
subjected to any treatment, it is sometimes argued that
antibiotics are diluted in the recipient waters in compari-
son with therapeutic concentrations and may not cause
any harm. However, it is widely recognized that exposure
to sub-therapeutic concentrations over long periods of
time provides ideal conditions for the transfer of resis-
tance genes. Use of non-culture techniques is important
to understand the dynamics of transfer of antibiotic resis-
tance genes. This was not possible in the present study,
due to limited resources. However, we plan to use these
techniques in future studies.
As regards the presence of resistant bacteria in the
wastewater, treatment systems can be a way of combating
this problem, as it has been shown that resistant bacteria
are eliminated relatively efficiently in wastewater treat-
ment plants [3]. Further, from the point of view of low-
and middle-income countries, low-cost, environment-
friendly techniques could be designed and developed for
the removal of antibiotics from wastewater using meth-
ods developed to simultaneously remove resistant bacte-
ria. This may offer a comprehensive solution to the
problem of antibiotic resistance development in the
aquatic environment. We expect that the results of this
study will be helpful in creating a basis for further scien-
tific enquiry in India and other countries regarding the
presence of emerging contaminants like antibiotics in
environment and its impact on public health.
Conclusions
Ciprofloxacin was the most common antibiotic pre-
scribed in the studied hospital, and the concentration of
this compound was highest both in the hospital wastewa-
ter and in the downstream drain system. The antibiotic
residue levels were above the levels that can cause gen-
toxic effects and modify bacterial strains. Samples col-
lected in the afternoon contained both a higher number
and higher levels of the antibiotics compared to samples
collected in the morning hours. There was a positive cor-
relation between quantities of antibiotics prescribed in
the hospital and their residue levels in the hospital waste-
water. No antibiotics were detected in the municipal
water supply or in samples from the ground water supply,
which was a redeeming feature of the study.
Although, ciprofloxacin was the most prevalent antibi-
otic found in wastewater, E.coli from wastewater was not
resistant to it but showed intermediate behaviour in threeDiwan et al. BMC Public Health 2010, 10:414
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Page 8 of 8
samples. In contrast, no amikacin was found in the waste-
water, but E.coli  isolated from all wastewater samples
showed resistance to amikacin. More in-depth studies are
needed to assess the correlation between the quantity of
antibiotics prescribed and both the levels of antibiotic
residues in hospital effluent and the effects on the devel-
opment of bacterial resistance in the environment.
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